当前位置: 首页 > 期刊 > 《中国现代医生》 > 2021年第4期
编号:670440
三维适形放疗同步吉非替尼化疗治疗局部晚期肺腺癌的疗效
http://www.100md.com 2021年4月6日 中国现代医生 2021年第4期
     宋丽丽

    [摘要] 目的 探討局部晚期肺腺癌应用三维适形放疗同步吉非替尼化疗治疗的效果。 方法 选择2019年1月至2020年1月我院收治的晚期肺腺癌患者76例,按照随机数字表法分为两组,每组各38例。对照组实施三维适形放疗,观察组在此基础上同步吉非替尼化疗,比较两组的治疗效果、细胞因子水平[白细胞介素2(IL-2)、肿瘤坏死因子-α(TNF-α)、集落刺激因子(CSF)]及不良反应发生情况。 结果 观察组疾病控制率(DCR)、总有效率(RR)分别为97.37%、81.58%,均高于对照组的78.95%、52.63%,差异有统计学意义(P0.05)。 结论 局部晚期肺腺癌应用三维适形放疗同步吉非替尼化疗治疗的效果较好,安全性较高。

    [关键词] 肺腺癌;吉非替尼化疗;三维适形放疗;细胞因子水平;不良反应

    [中图分类号] R734.2 ? ? ? ? ?[文献标识码] B ? ? ? ? ?[文章编号] 1673-9701(2021)04-0072-03

    The efficacy of three-dimensional conformal radiotherapy combined with gefitinib chemotherapy for locally advanced lung adenocarcinoma

    SONG Lili

    Department Ⅴ of Oncology, Jiamusi Tumor Hospital in Heilongjiang Province, Jiamusi ? 154002, China

    [Abstract] Objective To investigate the efficacy of three-dimensional conformal radiotherapy combined with gefitinib chemotherapy for locally advanced lung adenocarcinoma. Methods A total of 76 patients with advanced lung adenocarcinoma admitted to our hospital from January 2019 to January 2020 were selected and divided into the observation group(n=38) and the control group (n=38) according to the random number table method. The control group was treated with three-dimensional conformal radiotherapy ......

您现在查看是摘要页,全文长 10781 字符